Review

Advances in the Treatment of Cognitive Impairment in Major Depressive Disorder: Innovations and Research Challenges

Akansha Thakur Parag Jain M. Sharma N. Chauhan Nousheen Khatoon Deepika Sahu Ajazuddin Shekhar Tamrakar

Aug 2026 · Current Behavioral Neuroscience Reports · Vol 13 · 0 citations · 131 references

TL;DR

The neurobiological basis of cognitive impairment in MDD is explored, key biomarkers associated with these deficits are identified, and their implications for diagnosis, prognosis, and therapeutic intervention are discussed.

DOI Semantic Scholar

View source

Similar papers

Review Sep 2026

Why the body matters in major depressive disorder: neuroimaging findings of somatic symptoms and ongoing challenges.

A framework is provided for understanding the neural substrates of somatic symptoms in MDD, developing somatic phenotype-based biomarkers and targeted neuromodulation therapies, and integrating systems-level neuroimaging into precision psychiatry to advance biologically informed diagnosis/treatment.

Wei-Yan Wang, Xiang Wang · Behavioural Brain Research · 0 citations

Open access Sep 2026

Cognitive Reserve as a Stratification Factor for Cognitive Impairment and Disease Progression in Major Depressive Disorder.

The moderating effect of CR on the brain network-cognition association provides a neurobiological rationale for this vulnerability and supports incorporating CR into routine clinical assessment to guide risk stratification and personalized treatment planning.

M. Gruber, Henrike Renaud, M. Mauritz et al. · Psychotherapy and Psychosoma... · 0 citations

Open access Sep 2026

674. Cognitive and neurobiological indicators of risk and prognosis in mood disorders

Abstract Background Mood disorders are major contributors to the global burden of disease. There is a critical need for reliable markers that can identify individuals at elevated risk for developing mood disorders and predict poor prognosis among those already affected, in order to guide personalized interventions. Aim...

A. Sankar, B. Ozenne, V. Dam et al. · International Journal of Neu... · 0 citations

Review Open access Sep 2026

How Does Exercise Improve Executive Function During Recovery from Major Depressive Disorder? A Narrative Review

An Integrated Exercise–Neurobiology Model linking exercise prescription with coordinated physiological and neurobiological adaptations that may guide future mechanistic research and precision exercise interventions is proposed.

Adam Tomczak, P. Ziajka, Agnieszka Zwolińska et al. · Quality in Sport · 0 citations

Review Open access Sep 2026

Treatment-Resistant Depression: A Literature Review of Innovative and Emerging Treatment Strategies

Introduction and objective: Major depressive disorder (MDD) is a heterogeneous psychiatric condition characterized by affective, cognitive and somatic symptoms that considerably impair daily functioning. It is defined clinically by prolonged low mood, diminished interest or pleasure, and a range of associated disturban...

Maciej Kisielewski, Natalia Fidut, Jakub Skrzypek et al. · Quality in Sport · 0 citations

Open access Aug 2026

Baseline cortical structural features are associated with depressive and cognitive improvement in major depressive disorder

Baseline cortical morphometric features were associated with clinical and cognitive changes following antidepressant treatment in MDD, and single-ROI LOOCV models based on left cuneus and left SFC FD showed cross-validated associations with symptom improvement.

Yingna Li, Shuping Tian, Siyan Zan et al. · BMC Psychiatry · 0 citations